Tamanna Ratti Roshan Lal receives Sanofi Genzyme/ACMG Foundation Genetics Training Award
Recognized for her work in Clinical Biochemical Genetics, Tamanna Ratti Roshan Lal MB ChB was honored as the recipient of the Sanofi Genzyme Award presented by the ACMG Foundation for Genetic and Genomic Medicine during the 2017 ACMG Annual Clinical Genetics Meeting in Phoenix, Arizona.
The mission of the Sanofi Genzyme/ACMG Foundation Award is to support training programs that advance genetics education, research and standards of practice in medical genetics, to develop and expand clinical and laboratory expertise in medical genetics, and to initiate and develop a broad-based infrastructure for industry funding of high quality projects in the fields of medical genetics. The award grants $75,000 per year to the recipient's institution selected by the ACMG Foundation through a competitive process and will provide for the sponsorship of one year of the trainees' clinical genetics subspecialty in biochemical genetics following residency.
The awardee will have the opportunity to participate in an in-depth clinical and research experience at a premier medical center with expertise and significant clinical volume in the area of biochemical genetics.
With a strong interest in Lysosomal Storage Diseases, Dr. Roshan Lal's interests are geared toward improving the quality of life for children with genetic disorders, more specifically inborn errors of metabolism. As a board-certified Pediatrician and Chief Resident of the Department of Medical Genetics at The Johns Hopkins Hospital, she is passionate about clinically studying Lysosomal Storage diseases and advancing the care and treatment of these diseases in children. Currently, she is completing a fellowship in Medical Genetics at The Johns Hopkins Hospital in Baltimore, MD and is doing her clinical research at the National Institutes of Health in Bethesda, MD where she hopes to learn more about the disease and its severe impact on young children.
"I am humbled and honoured to be granted the Sanofi Genzyme/ACMG Foundation award. This award will provide a platform for me to gain more knowledge and experience as a medical biochemical geneticist. Such an opportunity will allow me to give the best clinical care possible for patients with rare metabolic diseases including lysosomal storage diseases as well as conduct clinical research to help identify new treatment modalities," said Dr. Roshan Lal.
"The Sanofi Genzyme/ACMG Foundation Clinical Genetics Award in Clinical Biochemical Genetics provides an important stimulus to the development of the genetics workforce. This fellowship allows Dr. Roshan Lal the chance to receive advanced clinical and research training in biochemical genetics, a very rapidly advancing field of medical practice," said Bruce R. Korf, MD, PhD, FACMG, president of the ACMG Foundation.
The ACMG Foundation is honored to have Sanofi Genzyme as a member of its Corporate Partners Program. For more information about the Corporate Partners Program and other ways to support the work of the ACMG Foundation, please visit http://www.acmgfoundation.org.
Note to editors: To arrange interviews with experts in medical genetics, contact Kathy Beal, MBA, ACMG Director of Public Relations at [email protected]
The ACMG Foundation for Genetic and Genomic Medicine (http://www.acmgfoundation.org), a 501(c)(3) nonprofit organization, is a community of supporters and contributors who understand the importance of medical genetics and genomics and genetic counseling in healthcare. Established in 1992, the ACMG Foundation supports the American College of Medical Genetics and Genomics' mission to "translate genes into health" by raising funds to promote the profession of medical genetics and genomics to medical students, to fund the training of future medical geneticists, to support best-practices and tools for practicing physicians and laboratory directors, to promote awareness and understanding of our work in the general public, and much more.
Kathy Ridgely Beal, MBA